 SALT LAKE CITY, Jan. 04, 2023 GLOBE NEWSWIRE -- Myriad Genetics, Inc., NASDAQ: MYGN, a leader in genetic testing and precision medicine, today announced Paul J. Diaz, president and chief executive officer, and Dale Muzzey, chief scientific officer, will present at the 41st Annual J.P. Morgan JPM Healthcare Conference on Monday, Jan. 9, 2023 at 4:30 p.m. PST7:30 p.m. EST. 